AI in Health and Care Award Round 3
Fund Name: AI in Health and Care Award Round 3
Project Length: 12-36 months
Project Value: £500k-£7m
The AI in Health and Care Award will deploy £140m over three years to accelerate the testing and evaluation of the most promising AI technologies that meet the strategic aims set out in the NHS Long Term Plan. The competition is run in partnership with the Accelerated Access Collaborative (AAC) and NHSX. It is part of the NHS AI Lab announced by the Health Secretary in 2019. The AI in Health and Care Award supports AI technologies across the spectrum of development, from initial feasibility to evaluation within clinical pathways in the NHS and social care settings, to the point that they could be nationally commissioned. Phases 1 and 2 aim to create a pipeline of products, interventions and services that are ready for wider testing. Key areas of focus for Phases 3 and 4 include:
- and intelligent operational automation.
- Phase 1 is intended to show the technical and clinical feasibility of the proposed concept, product or service. Awards are for a maximum of £150,000 over a 6-12 month period.
- Phase 2 is intended to develop and evaluate prototypes of demonstration units and generate early clinical safety and efficacy data. Award amounts are uncapped (any amount can be requested but must be reasonably justified), funding awards are per product, typically for 12-36 months.
- Phase 3 is intended to support first real-world testing in health and social care settings to develop further evidence of efficacy and preliminary proof of effectiveness, including evidence for routes to implementation to enable more rapid adoption.
- Phase 4 is intended to identify medium stage AI technologies that have market authorisation but insufficient evidence to merit large-scale commissioning or deployment. We will support testing and evaluation of these technologies within routine clinical or operational pathways to determine efficacy or accuracy, and clinical and economic impact. Grants are uncapped, funding awards are per technology, typically for 12-36 months.
Round 3 of this competition is open from 28/06/21. Competition 3 will not be open to Phase 1 applications. The AI Award is run as a two stage application process. You may only apply to one phase per product. Shortlisted applicants from stage 1 are invited to submit a full proposal at stage 2. Applications may be submitted by a small-to-medium-sized enterprise (SME), an NHS or social care organisation or service provider, a higher education institution, charity or local authority. Additionally for Phases 3 and 4, the call is open to large enterprises. Awards are uncapped (any amount can be requested but must be reasonably justified), funding awards are per product, typically for 12-36 months. The AI Award supports innovators and technologies across the spectrum of development, from concept through to initial NHS adoption and testing of the AI technology within clinical pathways.